Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.
Journal
EMBO molecular medicine
ISSN
1757-4684
Date Issued
2025-04-03
Author(s)
Hsieh, Meng-Lun
Lee, Hsiao-Lin
Hee, Siow-Wey
Chang, Chi-Fon
Yen, Hsin-Yung
Chen, Yi-An
Chen, Yet-Ran
Chou, Ya-Wen
Li, Fu-An
Ke, Yi-Yu
Chen, Shih-Yi
Hung, Ming-Shiu
Hung, Alfur Fu-Hsin
Huang, Jing-Yong
Chiu, Chu-Hsuan
Lin, Shih-Yao
Shih, Sheue-Fang
Hsu, Chih-Neng
Yeh, Teng-Kuang
Cheng, Ting-Jen Rachel
Liao, Karen Chia-Wen
Laio, Daniel
Chen, Tzu-Yu
Hu, Chun-Mei
Vogel, Ulla
Saar, Daniel
Kragelund, Birthe B
Tsou, Lun Kelvin
Tseng, Yu-Hua
Abstract
Correction to:EMBO Molecular Medicine. https://doi.org/10.1038/s44321-025-00216-4 | Published online 21 March 2025 In this article the affiliation details for Teng-Kuang Yeh were incorrectly given as “AltruBio Taiwan R&D Center, Taipei 114063, Taiwan” but should have been “Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan, Miaoli County 35053, Taiwan”. The original article has been corrected. In this article the e-mail address of the corresponding author Lun Kelvin Tsou was incorrect. The original article has been corrected.
SDGs
Type
corrigendum